We raise our target price to €26 per share from €22.5 and reiterate our BUY recommendation, as we find Fagron's recent step-up in growth targets is not yet priced in. Given high visibility on organic growth, attractive value and a strengthening track record, Fagron remains on the ING Benelux Favourites list.
In general, a weaker USD has a negative impact on Benelux stocks, particularly for companies with significant exports to the US. In this note we selected a list of companies with high US export exposure and we examine the potential impact on FY25 earninings. On top of the weak dollar, rising trade tensions or the introduction of tariffs further harm Benelux exporters. As the dollar depreciates against the euro, European goods become costlier for American consumers. At the same time, revenues ear...
Fagron increases share capital through exercise subscription rights Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of subscription rights, 85,000 new shares have been issued on 6 June 2025. In accordance with the Belgian transparency legislation, Fagron notes that its total share capital currently amounts to € 504,303,905.59. The total number of shares with voting rights after the issue amounts to 73,313,904 which is also ...
Fagron verhoogt kapitaal door uitoefening van inschrijvingsrechten Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 6 juni 2025 – 19:00u. CET Fagron verhoogt kapitaal door uitoefening van inschrijvingsrechten Fagron maakt bekend dat er op 6 juni 2025 85.000 nieuwe aandelen zijn uitgegeven als gevolg van de uitoefening van inschrijvingsrechten. Overeenkomstig de Belgische transparantiewetgeving deelt Fagron mee dat haar maatschappelijk kapitaal na de uitgifte € 504.303.905,59 bedraagt. Het totaal aantal stemrechtverlenende effecten na de uitgifte bedraagt 73.313.904, h...
In this June update, we've made four adjustments to the KBC Securities Dynamic Top Pick List: 1.Merus (Removed – 27 May) was removed following the release of strong interim Phase 2 data at the ASCO 2025 conference. Its lead asset, petosemtamab, in combination with Keytruda, showed a 63% overall response rate in first-line treatment of head and neck cancer—significantly outperforming Keytruda monotherapy. The resulting share price surge validated our investment thesis. 2. Adyen (Removed) has de...
CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER Antwerp, May 28, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) and Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) (“Golden Ocean”) are pleased to announce that they have signed an agreement and plan of merger (the “Merger Agreement”) for a stock-for-stock merger, as contemplated by the term sheet previously announced on 22 April 2025. The transaction is structur...
ForFarmers secures new credit facility Press release Lochem, 28 May 2025 ForFarmers secures new credit facility ForFarmers N.V. has signed a new credit facility for an amount of €150 million with an international banking syndicate. In addition, a €125 million working capital financing facility will become operational in mid-Q3 2025. To bridge the implementation period, a credit facility has been agreed with Rabobank. These facilities replace the previous financing agreement of €300 million. In addition, the activities of the joint ventures in Poland and Germany will, going forward, be...
ForFarmers sluit nieuwe kredietfaciliteit af Persbericht Lochem, 28 mei 2025 ForFarmers sluit nieuwe kredietfaciliteit af ForFarmers N.V. heeft een nieuwe kredietfaciliteit ondertekend ter waarde van €150 miljoen met een internationaal bankensyndicaat. Tevens zal medio Q3 2025 een werkkapitaal financiering van €125 miljoen operationeel zijn. Voor de overbrugging van de periode van implementatie van deze werkkapitaal financiering is een kredietfaciliteit met Rabobank afgesloten. Deze aanpak vervangt de vorige financieringsovereenkomst die €300 miljoen bedroeg. Daarnaast zijn de activiteit...
CMB.TECH results general meetings Antwerp, May 22, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) announces that today the General Meeting of Shareholders has approved the annual accounts for the year ended 31 December 2024. All other resolutions proposed by CMB.TECH’s Supervisory Board have also been approved. Reappointment of Supervisory Board members Shareholders voted to reappoint independent director Julie De Nul as Supervisory Board member. Furthermore, the General Shareholder Meeting approved the Resignation of Mr. Patri...
CMB.TECH announces Q1 2025 results CMB.TECH ANNOUNCES Q1 2025 RESULTS 1 BILLION USD CONTRACT BACKLOG ADDED ANTWERP, Belgium, 21 May 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) reported its non-audited financial results today for the first quarter ended 31 March 2025. HIGHLIGHTS Financial highlights: Profit of USD 40.4 million in Q1 2025CMB.TECH increases its contract backlog by USD 921 million (to USD 2.94 billion) Corporate highlights: CMB.TECH buys Hemen stake in Golden OceanTerm sheet signed for a stock-for-stock merger transac...
Update on and end of share buy-back programme ForFarmers Lochem, 20 May 2025 Update on and end of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 37,881 shares on 19 May 2025. The shares were repurchased at an average price of €4.36 per share, for a total amount of €165,260. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 17 April 2025. The authorisation concerns the buy-back of shares for ForFarmers to fulfil its obligations arising from (depositary receipts for) share...
Voortgang en einde inkoopprogramma eigen aandelen ForFarmers Lochem, 20 mei 2025 Voortgang en einde inkoopprogramma eigen aandelen ForFarmers ForFarmers N.V. (ForFarmers) heeft 37.881 aandelen ingekocht op 19 mei 2025. De aandelen zijn ingekocht met een gemiddelde prijs van €4,36 per aandeel, voor een totaalbedrag van €165.260. Deze inkopen zijn gedaan in overeenstemming met de machtiging verleend door de Algemene Vergadering van Aandeelhouders van ForFarmers op 17 april 2025. De machtiging betreft de inkoop van eigen aandelen zodat ForFarmers haar verplichtingen kan nakomen die voortv...
Update of share buy-back programme ForFarmers Lochem, 19 May 2025 Update of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 212,721 shares in the period from 12 May 2025 through 16 May 2025. The shares were repurchased at an average price of €4.20 per share, for a total amount of €892,460. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 17 April 2025. The authorisation concerns the buy-back of shares for ForFarmers to fulfil its obligations arising from (depositary rece...
Voortgang inkoopprogramma eigen aandelen ForFarmers Lochem, 19 mei 2025 Voortgang inkoopprogramma eigen aandelen ForFarmers ForFarmers N.V. (ForFarmers) heeft 212.721 aandelen ingekocht in de periode van 12 mei 2025 tot en met 16 mei 2025. De aandelen zijn ingekocht met een gemiddelde prijs van €4,20 per aandeel, voor een totaalbedrag van €892.460. Deze inkopen zijn gedaan in overeenstemming met de machtiging verleend door de Algemene Vergadering van Aandeelhouders van ForFarmers op 17 april 2025. De machtiging betreft de inkoop van eigen aandelen zodat ForFarmers haar verplichtingen kan ...
Five Directors at Fagron NV bought/sold 189,367 shares at between 16.230EUR and 20.506EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Fagron shareholders approve all voting items AGM Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 May 2025 – 7PM CET Fagron shareholders approve all voting items AGM Fagron, the leading global player in pharmaceutical compounding, held its annual general shareholders meeting today, where all the voting items were approved. ResolutionsThe annual general meeting approved, amongst other things, Fagron’s annual financial statements and dividend proposal of €0.35 per share for the fiscal year 2024, the remuneration policy and the appointment of the statutory auditor fo...
Aandeelhouders Fagron keuren alle agendapunten van de jaarvergadering goed Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 12 mei 2025 – 19:00u CET Aandeelhouders Fagron keuren alle agendapunten van de jaarvergadering goed Fagron, de toonaangevende mondiale speler in farmaceutische bereidingen, hield vandaag haar jaarlijkse algemene vergadering van aandeelhouders, waarbij alle ingediende voorstellen werden goedgekeurd. BesluitenDe jaarvergadering heeft onder andere Fagron’s jaarrekening en het dividendvoorstel van €0,35 per aandeel over het boekjaar 2024, het remunera...
CMB.TECH announces Q1 2025 results on 21/05/25 Antwerp, May 12, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its first quarter 2025 earnings prior to market opening on Thursday 21 May 2025 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. The call will be a webcast with an accompanying slideshow. You can find the details of this conference call below and on the of the website. The presentation, recording & transcript will also be available on this page. Webcast...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.